English Archives | Page 10 of 20 | SenzaGen

SenzaGen has completed the acquisition of VitroScreen S.r.l.

SenzaGen completes a directed share issue of SEK 30 million

SenzaGen intends to carry out a directed share issue

SenzaGen enters into agreement to acquire 100 percent of the shares in VitroScreen

SenzaGen presents accelerated growth strategy and invitation to Capital Markets Day

SenzaGen receives SEK 0.7m order for GARD®skin from one of the world’s largest pharmaceuticals companies

SenzaGen’s 2021 Half-Year Report: Positive ESAC opinion on GARD®skin and expanded range of tests open up new commercial opportunities

SenzaGen appoints Peter Nählstedt as new CEO

Invitation to SenzaGen’s 2021 half year report conference call on Aug 19 at 10.30 CET

SenzaGen receives SEK 0.65 million order for in vitro skin allergy and irritation tests from global consumer product company

Subscribe

Prenumerera